Home > Healthcare > Cartilage Repair Market
Cartilage Repair Market size was valued at USD 708.1 million in 2022 and is estimated to reach around USD 1.8 billion by 2032. Advancements in regenerative medicine, including stem cell therapy and growth factor treatments, are providing promising non-surgical options for cartilage repair, contributing to market progress.
To understand key trends  
Download Free Sample
Increased awareness of the importance of cartilage health and the availability of cartilage repair options has led more people to seek treatment for joint pain and injuries. Further, the introduction of biological products, such as autologous chondrocyte implantation (ACI) and cartilage-derived scaffolds, has enhanced the effectiveness of cartilage repair, boosting demand for these treatments. Moreover, as healthcare expenditure continues to increase in many regions, patients have more access to cartilage repair procedures and technologies.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Cartilage Repair Market Size in 2022: | USD 708.1 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 10.1% |
2032 Value Projection: | USD 1,878.5 Million |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 190 |
Tables, Charts & Figures: | 384 |
Segments covered: | Modality, Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
To understand market opportunities  
Download Free Sample
Cartilage repair refers to the process of restoring damaged or injured cartilage, a tough and flexible connective tissue that covers the ends of bones in joints, such as the knee, hip, and shoulder. Cartilage serves as a cushion and provides a smooth surface for joint movement. When cartilage is damaged due to injury, degeneration, or disease, it can lead to pain, reduced joint function, and the development of conditions like osteoarthritis.
The cartilage repair market experienced a negative impact due to the COVID-19 pandemic. Elective surgeries, including many cartilage repair procedures, were postponed, or cancelled to allocate healthcare resources for COVID-19 patients. This led to a decline in the number of surgeries and a reduction in revenue for healthcare providers and manufacturers of cartilage repair products. Patients were often reluctant to seek medical care for non-urgent orthopedic issues, further impacting the market. However, with the gradual resumption of elective procedures and an increased focus on regenerative medicine, the cartilage repair industry is expected to rebound, but recovery may take time.
Osteoarthritis is a common degenerative joint condition characterized by the breakdown of cartilage in the joints. As the population ages and obesity rates rise, the prevalence of osteoarthritis has been steadily increasing. For instance, according to the Centers for Disease Control and Prevention (CDC), osteoarthritis affects over 32.5 million adults in the U.S.
To understand key market trends  
Download Free Sample
The market by modality is categorized into cell based, and non-cell based. The cell-based segment accounted for around USD 450 million revenue in 2022. Cell-based treatments can be tailored to the patient's specific needs. This customization can lead to more effective and targeted cartilage repair, potentially improving patient outcomes.
To understand key market trends  
Download Free Sample
Based on type, the cartilage repair market is bifurcated into hyaline cartilage and fibrocartilage. The hyaline cartilage segment accounted for over 53% market share in 2022 and is projected to record highest growth during the forecast period.
Based on application, the cartilage repair market is segmented into knee, hip, and others. The knee segment held significant share and accounted for over USD 373 million in 2022.
The cartilage repair market by end-use is categorized into hospitals and clinics, and ambulatory surgical centers. The hospitals and clinics segment was valued at USD 547 million revenue in 2022. Primary care physicians often refer patients with joint issues to orthopedic specialists in hospitals and clinics. This referral process has increased the number of patients seeking cartilage repair services in these settings.
To understand regional trends  Download Free Sample
North America cartilage repair market accounted for over USD 364 million revenue in 2022 and is predicted to witness substantial market growth over the forecast timeline. Health insurance coverage in North America often includes orthopedic procedures, making cartilage repair accessible to a larger portion of the population.
The cartilage repair industry is competitive in nature, with leading companies competing to offer superior products in this business space. Prominent players such as Zimmer Biomet, Vericel Corporation, CONMED Corporation, Arthrex, Inc., and Stryker Corporation hold a significant share in this market. These companies are diligently directing their efforts towards continuous product innovation to improve their market presence.
Some of the eminent market participants operating in the cartilage repair industry include:
Click here to Buy Section of this Report
By Modality, 2018-2032 (USD Million)
By Type, 2018-2032 (USD Million)
By Application, 2018-2032 (USD Million)
By End-use, 2018-2032 (USD Million)
The above information is provided for the following regions and countries: